Rezolute Inc (RZLT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.29
• Market Cap: $338.77M
• EPS: $-0.93
• 52-Week High: $11.46
• 52-Week Low: $1.07

Market Sentiment

Rezolute Inc currently has a Bearish sentiment score of -0.41.

About Rezolute Inc

Rezolute, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, dedicated to developing innovative therapies for rare and metabolic diseases. The company boasts a promising pipeline targeting significant unmet medical needs, underpinned by its commitment to scientific advancement and clinical excellence. Through strategic collaborations and a focus on improving patient outcomes, Rezolute is uniquely positioned to make a substantial impact in the biophar...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Rezolute Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RZLT pay dividends?

Rezolute Inc (RZLT) does not currently pay a regular dividend.

What is RZLT's market cap?

Rezolute Inc (RZLT) has a market capitalization of $338.77M with a current stock price of $3.29.